Back
Myriad Genetics Vs. Globus Medical Industry Stock Comparison
Sell
16
MYGN
Myriad Genetics
Last Price:
15.04
Seasonality Move:
18.24%
Buy
68
GMED
Globus Medical
Last Price:
84.83
Seasonality Move:
7.22%
Sell
16
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy, Sell or Hold?
- The current Myriad Genetics [MYGN] share price is $15.30. The Score for MYGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- MYGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
68
Globus Medical (GMED)
is a Buy
Is Globus Medical a Buy, Sell or Hold?
- The current Globus Medical [GMED] share price is $83.59. The Score for GMED is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GMED is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MYGN Stock Price Chart
What is Myriad Genetics's stock price today?
-
The Myriad Genetics share price today is $15.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
GMED Stock Price Chart
What is Globus Medical's stock price today?
-
The Globus Medical share price today is $83.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMED is experiencing buying pressure, which is a positive indicator for future bullish movement.
MYGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.29 | Sell |
| Relative Strength Index (14 RSI): | 19.49 | Sell |
| Chaikin Money Flow: | 619490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.08 - 22.24) | Sell |
| Bollinger Bands (100): | (21.09 - 28.73) | Sell |
GMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.75 | Buy |
| Relative Strength Index (14 RSI): | 70.06 | Buy |
| Chaikin Money Flow: | 612260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.56 - 81.8) | Buy |
| Bollinger Bands (100): | (68.44 - 76.3) | Buy |
MYGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.71 | Sell |
| 20-day SMA: | 18.2 | Sell |
| 50-day SMA: | 22.79 | Sell |
| 200-day SMA: | 23.48 | Sell |
| 8-day EMA: | 15.86 | Sell |
| 20-day EMA: | 17.95 | Sell |
| 50-day EMA: | 21.27 | Sell |
| 200-day EMA: | 22.98 | Sell |
GMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.36 | Buy |
| 20-day SMA: | 78.68 | Buy |
| 50-day SMA: | 74.07 | Buy |
| 200-day SMA: | 64.91 | Buy |
| 8-day EMA: | 82 | Buy |
| 20-day EMA: | 79.37 | Buy |
| 50-day EMA: | 75.61 | Buy |
| 200-day EMA: | 67.26 | Buy |
Myriad Genetics Earnings Growth & MYGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.00 per share.
Globus Medical Earnings Growth & GMED Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.44 per share.
Myriad Genetics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Globus Medical Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||